These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31559512)

  • 41. Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes.
    Abel EE; Kane-Gill SL; Seybert AL; Kellum JA
    Am J Health Syst Pharm; 2012 Sep; 69(18):1559-67. PubMed ID: 22935938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparisons between diluted thrombin time, ecarin chromogenic assays, and UPLC-MS for plasma level dabigatran quantification: Results from DRIVING study.
    de Fautereau-Vassel A; Mokhtarian A; Mangenot M; Krekounian O; Kousignian I; Delavenne X; Curis E; Gouin-Thibault I; Siguret V
    Int J Lab Hematol; 2024 Feb; 46(1):120-127. PubMed ID: 37710085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel Monitoring and Dose Adjustment of Argatroban, a Direct Thrombin Inhibitor, to Maintain Therapeutic Anticoagulation in a Patient With Antiphospholipid Antibody Syndrome, Heparin-Induced Thrombocytopenia, and COVID-19 Pneumonia.
    Ryan CE; Newman KA; Roberts RJ; Frydman GH; Rosovsky RP
    Crit Care Explor; 2023 Apr; 5(4):0903. PubMed ID: 37114202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alternative anticoagulation during cardiovascular procedures in pediatric patients with heparin-induced thrombocytopenia.
    Argueta-Morales IR; Olsen MC; DeCampli WM; Munro HM; Felix DE
    J Extra Corpor Technol; 2012 Jun; 44(2):69-74. PubMed ID: 22893986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Hursting MJ
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct thrombin inhibitors fail to reverse the negative effects of heparin on lung growth and function after murine left pneumonectomy.
    Tsikis ST; Hirsch TI; Klouda T; Fligor SC; Pan A; Joiner MM; Wang SZ; Quigley M; Devietro A; Mitchell PD; Kishikawa H; Yuan K; Puder M
    Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L213-L225. PubMed ID: 38113296
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays.
    Wakui M; Fujimori Y; Nakamura S; Kondo Y; Kuroda Y; Oka S; Nakagawa T; Katagiri H; Murata M
    J Clin Pathol; 2019 Dec; 72(12):817-824. PubMed ID: 31366633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pilot, prospective evaluation of a direct thrombin inhibitor, bivalirudin (Angiomax), in patients undergoing lower extremity bypass.
    Kashyap VS; Bishop PD; Bena JF; Rosa K; Sarac TP; Ouriel K
    J Vasc Surg; 2010 Aug; 52(2):369-74. PubMed ID: 20478686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples.
    Helin TA; Lemponen M; Hjemdahl P; Rönquist-Nii Y; Lassila R; Joutsi-Korhonen L
    Thromb Res; 2015 Jul; 136(1):154-60. PubMed ID: 25981140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ecarin chromogenic assay--a new method for quantitative determination of direct thrombin inhibitors like hirudin.
    Lange U; Nowak G; Bucha E
    Pathophysiol Haemost Thromb; 2003 Jul-2004 Aug; 33(4):184-91. PubMed ID: 15583447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopenia.
    Gilmore JF; Adams CD; Blum RM; Fanikos J; Anne Hirning B; Matta L
    Am J Hematol; 2015 Aug; 90(8):E143-5. PubMed ID: 25913754
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations.
    Jaffer IH; Chan N; Roberts R; Fredenburgh JC; Eikelboom JW; Weitz JI
    J Thromb Haemost; 2017 Dec; 15(12):2377-2387. PubMed ID: 28976630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays.
    Douxfils J; Lessire S; Dincq AS; Hjemdahl P; Rönquist-Nii Y; Pohanka A; Gourdin M; Chatelain B; Dogné JM; Mullier F
    Thromb Haemost; 2015 Apr; 113(4):862-9. PubMed ID: 25519251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values.
    Gosselin RC; Dager WE; King JH; Janatpour K; Mahackian K; Larkin EC; Owings JT
    Am J Clin Pathol; 2004 Apr; 121(4):593-9. PubMed ID: 15080313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of lepirudin and argatroban outcomes.
    Smythe MA; Stephens JL; Koerber JM; Mattson JC
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):371-4. PubMed ID: 16244762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
    Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
    J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and implementation of a nurse-driven, sliding-scale nomogram for bivalirudin in the management of heparin-induced thrombocytopenia.
    Burcham PK; Abel EE; Gerlach AT; Murphy CV; Belcher M; Blais DM
    Am J Health Syst Pharm; 2013 Jun; 70(11):980-7. PubMed ID: 23686604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).
    Guy S; Kitchen S; Makris M; M Maclean R; Saccullo G; Vanveen JJ
    Clin Appl Thromb Hemost; 2021; 27():10760296211066945. PubMed ID: 34905962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment options for heparin-induced thrombocytopenia.
    Greinacher A
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.